ASX:OSL - Oncosil Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Oncosil Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$0.16 +0.01 (+6.80 %) (As of 02/20/2020 04:00 PM ET) Add Compare Today's RangeA$0.15Now: A$0.16▼A$0.1650-Day RangeA$0.15MA: A$0.17▼A$0.2152-Week RangeA$0.02Now: A$0.16▼A$0.22Volume1.11 million shsAverage VolumeN/AMarket Capitalization$99.02 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email OncoSil Medical Limited, a medical device company, focuses on the development of localized treatments for cancer in Australia. Its lead product is OncoSil, a brachytherapy device comprising OncoSil Phosphorous-32 Microparticles and OncoSil Diluent, which implants a pre-determined dose of beta radiation emitting isotope directly into cancerous tissue for the treatment of pancreatic and liver cancer. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in June 2013. OncoSil Medical Limited is headquartered in North Sydney, Australia. Industry, Sector and Symbol Stock Exchange ASX Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolASX:OSL Previous Symbol CUSIPN/A CIKN/A Webhttp://www.oncosil.com.au/ Phone61 2 9223 3344Debt Debt-to-Equity Ratio0.45 Current Ratio11.69 Quick Ratio11.59Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$3.63 million Price / Sales27.31 Cash FlowA$0.01 per share Price / Cash Flow14.58 Book ValueA$0.02 per share Price / Book9.24Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares630,708,992Market Cap$99.02 million Next Earnings DateN/A OptionableNot Optionable Receive OSL News and Ratings via Email Sign-up to receive the latest news and ratings for OSL and its competitors with MarketBeat's FREE daily newsletter. Oncosil Medical (ASX:OSL) Frequently Asked Questions What is Oncosil Medical's stock symbol? Oncosil Medical trades on the ASX under the ticker symbol "OSL." Has Oncosil Medical been receiving favorable news coverage? Media coverage about OSL stock has trended positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Oncosil Medical earned a media sentiment score of 2.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Oncosil Medical. Who are some of Oncosil Medical's key competitors? Some companies that are related to Oncosil Medical include Volpara Health Tech (VHT), Profound Medical (PRN), Akumin (AKU), Exagen (XGN), Senseonics (SENS), Renalytix Ai (RENX), Palatin Technologies (PTN), Yourgene Health (YGEN), MaxCyte (MXCT), Lexagene (LXG), BARD1 Life Sciences (BD1), Oncimmune (ONC), Sernova (SVA), GeneNews (GEN) and SQI Diagnostics (SQD). What other stocks do shareholders of Oncosil Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Oncosil Medical investors own include Twitter (TWTR), Procter & Gamble (PG), WiseTech Global (WTC), Qube (QUB), Charter Hall Education Trust (CQE) and APA Group (APA). Who are Oncosil Medical's key executives? Oncosil Medical's management team includes the folowing people: Mr. Daniel Kenny B.Sc., CEO, MD & Exec. DirectorMr. Tom Milicevic B.Comm, FCPA, MBA MGSM, CFO & Company Sec. (Age 47)Mr. Michael Warrener, Global Sales & Marketing DirectorDr. Ashish Soman, Chief Medical OfficerDr. David C. James, Global Head of Manufacturing Operations What is Oncosil Medical's stock price today? One share of OSL stock can currently be purchased for approximately A$0.16. How big of a company is Oncosil Medical? Oncosil Medical has a market capitalization of $99.02 million and generates $3.63 million in revenue each year. View Additional Information About Oncosil Medical. What is Oncosil Medical's official website? The official website for Oncosil Medical is http://www.oncosil.com.au/. How can I contact Oncosil Medical? The company can be reached via phone at 61 2 9223 3344. MarketBeat Community Rating for Oncosil Medical (ASX OSL)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 13 (Vote Outperform)Underperform Votes: 12 (Vote Underperform)Total Votes: 25MarketBeat's community ratings are surveys of what our community members think about Oncosil Medical and other stocks. Vote "Outperform" if you believe OSL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OSL will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/20/2020 by MarketBeat.com StaffFeatured Article: What is a capital gain?
